RUA Life Sciences (LON:RUA) Trading Down 1.4% – Here’s What Happened

by · The Cerbat Gem

RUA Life Sciences plc (LON:RUA – Get Free Report)’s share price fell 1.4% during mid-day trading on Wednesday . The company traded as low as GBX 11.63 ($0.15) and last traded at GBX 12.08 ($0.16). 208,450 shares changed hands during mid-day trading, an increase of 17% from the average session volume of 177,495 shares. The stock had previously closed at GBX 12.25 ($0.16).

RUA Life Sciences Stock Down 4.8 %

The firm has a market cap of £7.31 million, a P/E ratio of -2.74 and a beta of 1.21. The firm’s 50-day moving average price is GBX 12.60 and its 200 day moving average price is GBX 12.11. The company has a debt-to-equity ratio of 5.42, a current ratio of 9.01 and a quick ratio of 7.32.

Insider Buying and Selling at RUA Life Sciences

In other RUA Life Sciences news, insider William D. Brown purchased 25,000 shares of RUA Life Sciences stock in a transaction dated Monday, February 3rd. The shares were bought at an average cost of GBX 13 ($0.17) per share, for a total transaction of £3,250 ($4,214.21). 51.33% of the stock is currently owned by insiders.

RUA Life Sciences Company Profile

(Get Free Report)

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Featured Stories